Related Experiment Video
Updated: Jun 22, 2026
06:49
Evaluation of a Smartphone-based Human Activity Recognition System in a Daily Living Environment
Published on: December 11, 2015
Evaluation of a method for activity estimation in Sm-153 EDTMP imaging.
Eleonora Vanzi1, Dario Genovesi, Fabio Di Martino
1Department of Clinical Pathophysiology, Nuclear Medicine Unit, University of Florence, Florence 50134, Italy. e.vanzi@dfc.unifi.it
Medical Physics
|May 29, 2009
Summary
A new region of interest (ROI) based method (LS-ROI) improves absolute activity quantification in radionuclide therapy by overcoming partial volume effects. This technique offers more accurate dosimetry for small lesions, enhancing patient-specific treatment planning.
Area of Science:
- Nuclear Medicine
- Medical Physics
- Radiopharmaceutical Therapy
Background:
- Accurate absolute activity quantification is crucial for optimizing internal radionuclide dosimetry and patient-specific therapy.
- Traditional 3D SPECT image-based (IB) methods often underestimate radionuclide concentration due to the partial volume effect (PVE), particularly in small, diffuse lesions.
- PVE significantly impacts dosimetry accuracy, necessitating improved quantification techniques for effective radionuclide therapy.
Purpose of the Study:
- To introduce and evaluate a novel 3D region of interest (ROI) based quantification method (LS-ROI) for absolute activity assessment.
- To assess the LS-ROI method's capability in correcting for PVE and improving quantification accuracy, especially for small lesions.
- To compare the performance of LS-ROI against conventional 3D IB methods and a quantitative conjugate view approach (LS-ROI-AP).
Main Methods:
- Developed a 3D region of interest (ROI) based quantification method (LS-ROI) that estimates concentration directly from tomographic projection data.
- Applied LS-ROI to simulated data mimicking bone metastases treated with 153Sm-EDTMP and to real phantom data (NEMA phantom with spheres).
- Investigated the impact of segmentation errors and compared LS-ROI, LS-ROI-AP, and conventional 3D IB methods.
Main Results:
- LS-ROI recovered simulated concentration values within 20%, while the IB method underestimated small lesions by up to 49%.
- LS-ROI and LS-ROI-AP reduced bias to 13% on real phantom data, compared to 47% underestimation by the IB method in the smallest sphere.
- LS-ROI demonstrated superior performance in total skeleton retention evaluation (within 2% vs. 13% underestimation by IB), with comparable accuracy to LS-ROI-AP.
Conclusions:
- The LS-ROI method offers robust absolute activity quantification, particularly beneficial for small, diffused lesions in radionuclide therapy.
- LS-ROI provides a foundation for developing accurate patient-specific planning strategies in internal radionuclide treatments.
- Reliable lesion segmentation is essential for maximizing the benefits of the LS-ROI method in clinical applications.
